Risultati della ricerca - Scott R. Plotkin

Raffina i risultati
  1. 1
    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis di Jaishri O. Blakeley, Scott R. Plotkin

    Pubblicazione 2016
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1

    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 di Anna R. Terry, Justin T. Jordan, Lee H. Schwamm, Scott R. Plotkin

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature

    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature di Ana-Maria Vranceanu, Vanessa L. Merker, Elyse R. Park, Scott R. Plotkin

    Pubblicazione 2013
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab

    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab di Deva S. Jeyaretna, William T. Curry, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Glioblastoma care in the elderly

    Glioblastoma care in the elderly di Justin T. Jordan, Elizabeth R. Gerstner, Tracy T. Batchelor, Daniel P. Cahill, Scott R. Plotkin

    Pubblicazione 2015
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients

    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients di Scott R. Plotkin, Vanessa L. Merker, Alona Muzikansky, Fred G. Barker, William H. Slattery

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients

    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients di Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study

    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study di Anna R. Terry, Fred G. Barker, Lisa Leffert, Brian T. Bateman, Irene Souter, Scott R. Plotkin

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients di Scott R. Plotkin, Chris Halpin, Michael J. McKenna, Jay S. Loeffler, Tracy T. Batchelor, Fred G. Barker

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis di Miriam J. Smith, James A. Walker, Yiping Shen, Anat Stemmer‐Rachamimov, James F. Gusella, Scott R. Plotkin

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome di Daphne L. Wang, Kelly B. Smith, Sonia Esparza, Fawn A. Leigh, Alona Muzikansky, Elyse R. Park, Scott R. Plotkin

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2

    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2 di Scott R. Plotkin, Vanessa L. Merker, Chris Halpin, Dominique Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2 di Said Farschtschi, Vanessa L. Merker, David S. Wolf, Martin U. Schuhmann, Jaishri O. Blakeley, Scott R. Plotkin, Christian Hagel, Victor F. Mautner

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth di Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Achieving consensus for clinical trials

    Achieving consensus for clinical trials di Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

    Pubblicazione 2013
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  16. 16
    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate di Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, Burt Nabors, Brian H. Chon, Tracy T. Batchelor

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors

    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors di Hon Kit Wong, Johanna Lahdenranta, Walid S. Kamoun, Annie W. Chan, Andrea I. McClatchey, Scott R. Plotkin, Rakesh K. Jain, Emmanuelle di Tomaso

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis

    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis di Vanessa L. Merker, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Alona Muzikansky, Rosa Nguyen, Victor F. Mautner, Scott R. Plotkin

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey

    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey di Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial

    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial di Areej El‐Jawahri, Lisa Podgurski, April F. Eichler, Scott R. Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: